EPISODE · Jul 24, 2025 · 20 MIN
217. More Fat Loss, Less Muscle Loss? This Peptide Could Change the Game
Is GLP-2s the next level in fat loss or just another excuse to skip the work? In this episode of the Kris Gethin Podcast, I break down the most advanced GLP peptide on the market right now. You'll learn how this dual-action compound hits both GLP-1s and GIP receptors to accelerate fat loss, crush hunger, and improve metabolic function faster than older GLP-1s. I walk you through the real-world results my clients are seeing: 15 to 22 percent bodyweight drops, better blood sugar control, and renewed energy. But I also pull back the curtain on the downsides. Nausea. Gut issues. Muscle loss. All of it can happen. You'll discover how to use GLP-2s the right way. I also share a powerful transformation story from a friend who dropped over 130 pounds and built a physique he never thought possible. This episode gives you the tools to use modern science as fuel for your transformation, not a crutch to avoid effort. Listen now. Apply what you learn. And stop messing around. We Also Discuss: 01:27: How GLP-2s work: dual agonist targeting GLP-1s and GIP 03:46: Why GLP-2s outperform GLP-1s in fat loss and blood sugar control 05:52: GLP-2s vs GLP-1s: side-by-side comparison of results and side effects 08:26: The non-negotiables: training, diet, and recovery on GLP peptides 12:41: Real transformation: how one client lost 130 lbs and built muscle Thank You To our Sponsors: NAD + Cell Shield from Biostack Labs https://biostacklabs.com/kris BiOptimizers - code KRIS10 for 10% off https://bioptimizers.com/ Find more from Kris: Website: https://www.krisgethin.com/ Instagram: https://www.instagram.com/krisgethin/ Youtube: https://www.youtube.com/krisgethin 2 Shred: https://www.unmatchedsupps.com/products/2shred
NOW PLAYING
217. More Fat Loss, Less Muscle Loss? This Peptide Could Change the Game
No transcript for this episode yet
Similar Episodes
Dec 5, 2025 ·50m
Oct 9, 2025 ·33m
Oct 3, 2025 ·40m
Sep 11, 2025 ·31m
Aug 27, 2025 ·39m
Aug 18, 2025 ·54m